The FDA has approved the next-generation of Boston Scientific’s (NYSE:BSX) Watchman left atrial appendage closure (LAAC) device, the company announced today. The Marlborough, Mass.-based company describes the Watchman FLX as a permanent implant designed to close off the left atrial appendage and thus reduce the risk of stroke without the bleeding danger associated with blood-thinners. It […]
/PRNewswire/ — VieCure, a cancer care company, today announced that it is integrating e-prescribing and medication management solutions from health technology…
Blackford and Lucida Medical Partner to Enhance Prostate Care
/PRNewswire/ – 16 Bit Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted a De Novo marketing authorization for Rho™, an…
/PRNewswire/ — The U.S. Food and Drug Administration granted Sira Medical 510(k) clearance for its augmented reality preoperative surgical planning…
Under the agreement, the FDA will use rare powers to require repairs, replacements or refunds for recalled respiratory machines.
Data from NICO’s ENRICH trial, published in NEJM, demonstrates functional improvement for minimally-invasive parafascicular surgery (MIPS).
The Biden administration has launched a new effort to improve the ability of the U.S. to prevent, detect and respond to global health threats. Some…
Q Bio Inc., an innovator in medical imaging technology, today announced the launch of Tensor Field Mapping (TFM), a new technology for Magnetic Resona
Another wave of private equity-backed bankruptcies is expected this year, according to the Private Equity Stakeholder Project.
“Discover how OSF HealthCare is teaming up with Brand Engagement Network to develop AI assistants for primary care training, improving simulated training operat
